We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.88%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.05B
AUM Growth
+$375M
Cap. Flow
+$361M
Cap. Flow %
34.49%
Top 10 Hldgs %
24.89%
Holding
5,677
New
1,360
Increased
1,920
Reduced
1,136
Closed
1,108

Sector Composition

Rank Sector Weight
1 Financials 6.05%
2 Technology 5.64%
3 Industrials 5.17%
4 Consumer Discretionary 4.28%
5 Healthcare 3.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IXYS
3201
DELISTED
IXYS Corp
IXYS
$7K ﹤0.01%
667
-4,679
-88% -$50.9K
ZPIN
3202
DELISTED
Zhaopin Limited
ZPIN
$7K ﹤0.01%
500
SEV
3203
DELISTED
Sevcon, Inc.
SEV
$7K ﹤0.01%
707
-96
-12% -$977
SHOR
3204
DELISTED
ShoreTel, Inc.
SHOR
$7K ﹤0.01%
1,042
-856
-45% -$5.67K
NUTR
3205
DELISTED
Nutraceutical International Co
NUTR
$7K ﹤0.01%
317
+315
+15,750% +$7.5K
PPP
3206
DELISTED
Primero Mining Corp
PPP
$7K ﹤0.01%
2,517
-183
-7% -$337
UTEK
3207
DELISTED
Ultratech Inc.
UTEK
$7K ﹤0.01%
+282
New +$6.16K
EFUT
3208
DELISTED
eFuture Holding Inc. Ordinary Shares
EFUT
$7K ﹤0.01%
1,292
+500
+63% +$2.92K
APIC
3209
DELISTED
Apigee Corporation Common Stock
APIC
$7K ﹤0.01%
588
-3,170
-84% -$33.7K
COB
3210
DELISTED
CommunityOne Bancorp
COB
$7K ﹤0.01%
615
-509
-45% -$6.71K
PTX
3211
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$7K ﹤0.01%
+1,469
New +$9.59K
ZGNX
3212
DELISTED
Zogenix, Inc.
ZGNX
$7K ﹤0.01%
+868
New +$8.47K
AOI
3213
DELISTED
Alliance One International
AOI
$7K ﹤0.01%
425
+325
+325% +$6.71K
MHE
3214
DELISTED
BlackRock Massachusetts Tax-Exempt Trust
MHE
$7K ﹤0.01%
437
CYTR
3215
DELISTED
CytRx Corp
CYTR
$7K ﹤0.01%
520
-129
-20% -$2.15K
AWH
3216
DELISTED
Allied World Assurance Co Hld Lt
AWH
$7K ﹤0.01%
+200
New +$7.2K
HYGS
3217
DELISTED
Hydrogenics Corp
HYGS
$7K ﹤0.01%
983
-17
-2% -$136
CIZN
3218
DELISTED
Citizens Holding Co.
CIZN
$7K ﹤0.01%
305
+189
+163% +$4.06K
PSAU
3219
DELISTED
Invesco Global Gold and Precious Metals ETF
PSAU
$7K ﹤0.01%
300
-152
-34% -$3.12K
CSBK
3220
DELISTED
Clifton Bancorp Inc.
CSBK
$7K ﹤0.01%
+517
New +$7.73K
FCFP
3221
DELISTED
FIRST COMMUNITY FINANCIAL PARTNERS INC.
FCFP
$7K ﹤0.01%
+847
New +$7.53K
DWTI
3222
DELISTED
VelocityShares 3x Inverse Crude ETN linked to the S&P GSCI Crude Oil Index Excess Return
DWTI
$7K ﹤0.01%
100
CIFC
3223
DELISTED
CIFC LLC Common Shares
CIFC
$7K ﹤0.01%
1,007
-854
-46% -$6.11K
QGENF
3224
DELISTED
QIAGEN NV
QGENF
$7K ﹤0.01%
318
-4,598
-94% -$101K
TCF
3225
DELISTED
TCF Financial Corporation
TCF
$7K ﹤0.01%
+589
New +$7.79K

Similar funds

Tower Research Capital (TRC)'s Q2 2016 Portfolio in Review

As of Q2 2016, Tower Research Capital (TRC) held 5,677 positions worth $1.05B, up 56% from $672M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Tower Research Capital (TRC) deployed $361M of net new capital in Q2 2016, opening 1,360 new positions and adding to 1,920 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 247,708 shares worth $6.21M.

By sector, the portfolio is most concentrated in Financials at 6.1% of assets, up from 2.5% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $48M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2016 buy was iShares Russell 1000 Growth ETF: 247,708 shares worth $6.21M.
  • Tower Research Capital (TRC) added most to State Street SPDR Dow Jones Industrial Average ETF Trust in Q2 2016, an estimated $24.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2016 reduction was iShares Russell 2000 ETF, cutting an estimated $48M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q2 2016, selling an estimated $9.09M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 25% of its $1.05B portfolio in Q2 2016.
  • Tower Research Capital (TRC) opened 1,360 new positions and closed 1,108 in Q2 2016.
  • Tower Research Capital (TRC)'s portfolio value rose 56% quarter-over-quarter to $1.05B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2016, filed 10 Aug 2016.